⚙
AI-generated summary
by qwen3.7-flash, 2026-10-05
ⓘ
This review details the clinicopathologic and molecular features distinguishing benign mesonephric proliferations, mesonephric-derived tumors, and mesonephric-like adenocarcinoma, noting the latter’s association with endometriosis and other Müllerian neoplasms.
⚙
AI-generated deep summary
by qwen3.7-flash, 2026-10-04
· read from full text
ⓘ
This review article categorizes mesonephric and mesonephric-like proliferations of the gynecologic tract into benign and malignant entities, distinguishing them based on their embryological origins. The authors highlight that while true mesonephric adenocarcinomas arise from Wolffian duct remnants in the cervix, mesonephric-like carcinomas are Müllerian neoplasms that transdifferentiate, often showing distinct molecular profiles such as PIK3CA and PTEN alterations. A key diagnostic challenge addressed is the significant morphologic and immunohistochemical overlap between these two carcinoma types, requiring careful evaluation to determine the primary site and precursor lesions. Relevance to endometriosis: listed as a potential precursor lesion for mesonephric-like adenocarcinoma, though the paper's main focus is the pathological classification of rare gynecologic tumors rather than endometriosis itself.
Abstract
Mesonephric remnants are vestiges of Wolffian ducts located adjacent to the Müllerian ducts. Proliferations arising from these remnants are uncommon and classified as benign, including mesonephric hyperplasia, Gartner and rete cysts, papillary cystadenoma, rete adenoma, and female adnexal tumor of probable wolffian origin (only rare cases of the latter exhibited malignant behavior), or malignant, including mesonephric adenocarcinoma and carcinosarcoma. Morphologic evaluation aided by immunohistochemistry, especially in carcinomas, is the cornerstone to establish the correct diagnosis. In contrast to mesonephric adenocarcinoma, which arises predominantly in the cervix and is frequently associated with mesonephric hyperplasia, mesonephric-like adenocarcinoma is currently considered to be a neoplasm of Müllerian derivation that undergoes transdifferentiation into a Wolffian phenotype. There is significant morphologic, immunohistochemical, genetic and epigenetic overlap between mesonephric carcinoma and mesonephric-like carcinoma. However, distinctive features are seen in each of these entities, including primary site (cervix vs. corpus/extrauterine locations), associated precursors (mesonephric remnants/hyperplasia vs. atypical endometrial hyperplasia/endometriosis/other Müllerian neoplasm), and some differences in the immunohistochemical (more frequent ER and TTF1 positivity in mesonephric-like carcinoma) and molecular profiles (mesonephric-like adenocarcinoma more frequently harbors genetic alterations reported in other Müllerian tumors, such as PIK3CA, PTEN, and CTNNB1). In this review, we provide a detailed overview of the clinicopathologic and molecular features of benign mesonephric proliferations, mesonephric-derived tumors, and mesonephric-like adenocarcinoma, as well as their differential diagnoses.
Full text
1,972 characters
· extracted from
oa-doi-fallback
· click to expand
Mesonephric and Mesonephric-Like Proliferations of the Gynecologic Tract
- Lawrence Hsu Lin*
- Jelena Mirkovic†
- Elizabeth D. Euscher‡
Mesonephric remnants are vestiges of Wolffian ducts located adjacent to the Müllerian ducts. Proliferations arising from these remnants are uncommon and classified as benign, including mesonephric hyperplasia, Gartner and rete cysts, papillary cystadenoma, rete adenoma, and female adnexal tumor of probable wolffian origin (only rare cases of the latter exhibited malignant behavior), or malignant, including mesonephric adenocarcinoma and carcinosarcoma. Morphologic evaluation aided by immunohistochemistry, especially in carcinomas, is the cornerstone to establish the correct diagnosis. In contrast to mesonephric adenocarcinoma, which arises predominantly in the cervix and is frequently associated with mesonephric hyperplasia, mesonephric-like adenocarcinoma is currently considered to be a neoplasm of Müllerian derivation that undergoes transdifferentiation into a Wolffian phenotype. There is significant morphologic, immunohistochemical, genetic and epigenetic overlap between mesonephric carcinoma and mesonephric-like carcinoma. However, distinctive features are seen in each of these entities, including primary site (cervix vs. corpus/extrauterine locations), associated precursors (mesonephric remnants/hyperplasia vs. atypical endometrial hyperplasia/endometriosis/other Müllerian neoplasm), and some differences in the immunohistochemical (more frequent ER and TTF1 positivity in mesonephric-like carcinoma) and molecular profiles (mesonephric-like adenocarcinoma more frequently harbors genetic alterations reported in other Müllerian tumors, such as PIK3CA, PTEN, and CTNNB1). In this review, we provide a detailed overview of the clinicopathologic and molecular features of benign mesonephric proliferations, mesonephric-derived tumors, and mesonephric-like adenocarcinoma, as well as their differential diagnoses.
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.